Global Prostate Cancer Medicine Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Q: What are the significant segments operating in the market?

Market is segmented on the basis. Read More

Global Prostate Cancer Medicine Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID : 96280
Published On: Mar, 2022
Pages: 156
Pharmaceuticals and Healthcare

Buy @ $3500

The Prostate Cancer Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Prostate Cancer Medicine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Age Below 55 accounting for % of the Prostate Cancer Medicine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While LHRH Antagonists segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Prostate Cancer Medicine include AstraZeneca plc, Active Biotech, Bristol Myers-Squibb, Teva Pharmaceuticals Industries Ltd., and Johnson & Johnson, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Prostate Cancer Medicine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

LHRH Antagonists

LHRH Analogs

Antiandrogens

Pipeline Drugs for Hormonal Therapy

Market segment by Application, can be divided into

Age Below 55

Age 55-75

Age Above 75

Market segment by players, this report covers

AstraZeneca plc

Active Biotech

Bristol Myers-Squibb

Teva Pharmaceuticals Industries Ltd.

Johnson & Johnson

Pfizer Inc.

Bayer AG

Abbott Laboratories

Astellas Pharma Inc.

Roche Holding AG

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Prostate Cancer Medicine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Prostate Cancer Medicine, with revenue, gross margin and global market share of Prostate Cancer Medicine from 2019 to 2022.

Chapter 3, the Prostate Cancer Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Prostate Cancer Medicine market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Prostate Cancer Medicine research findings and conclusion, appendix and data source.

Frequently Asked Questions

What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

What are the significant segments operating in the market?

Market is segmented on the basis:

By Type
By Application
By Region
By Country
By Manufacturer

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Prostate Cancer Medicine

1.2 Classification of Prostate Cancer Medicine by Type

1.2.1 Overview: Global Prostate Cancer Medicine Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Prostate Cancer Medicine Revenue Market Share by Type in 2021

1.2.3 LHRH Antagonists

1.2.4 LHRH Analogs

1.2.5 Antiandrogens

1.2.6 Pipeline Drugs for Hormonal Therapy

1.3 Global Prostate Cancer Medicine Market by Application

1.3.1 Overview: Global Prostate Cancer Medicine Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Age Below 55

1.3.3 Age 55-75

1.3.4 Age Above 75

1.4 Global Prostate Cancer Medicine Market Size & Forecast

1.5 Global Prostate Cancer Medicine Market Size and Forecast by Region

1.5.1 Global Prostate Cancer Medicine Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Prostate Cancer Medicine Market Size by Region, (2017-2022)

1.5.3 North America Prostate Cancer Medicine Market Size and Prospect (2017-2028)

1.5.4 Europe Prostate Cancer Medicine Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Prostate Cancer Medicine Market Size and Prospect (2017-2028)

1.5.6 South America Prostate Cancer Medicine Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Prostate Cancer Medicine Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Prostate Cancer Medicine Market Drivers

1.6.2 Prostate Cancer Medicine Market Restraints

1.6.3 Prostate Cancer Medicine Trends Analysis

2 Company Profiles

2.1 AstraZeneca plc

2.1.1 AstraZeneca plc Details

2.1.2 AstraZeneca plc Major Business

2.1.3 AstraZeneca plc Prostate Cancer Medicine Product and Solutions

2.1.4 AstraZeneca plc Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 AstraZeneca plc Recent Developments and Future Plans

2.2 Active Biotech

2.2.1 Active Biotech Details

2.2.2 Active Biotech Major Business

2.2.3 Active Biotech Prostate Cancer Medicine Product and Solutions

2.2.4 Active Biotech Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Active Biotech Recent Developments and Future Plans

2.3 Bristol Myers-Squibb

2.3.1 Bristol Myers-Squibb Details

2.3.2 Bristol Myers-Squibb Major Business

2.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Product and Solutions

2.3.4 Bristol Myers-Squibb Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Bristol Myers-Squibb Recent Developments and Future Plans

2.4 Teva Pharmaceuticals Industries Ltd.

2.4.1 Teva Pharmaceuticals Industries Ltd. Details

2.4.2 Teva Pharmaceuticals Industries Ltd. Major Business

2.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Product and Solutions

2.4.4 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Teva Pharmaceuticals Industries Ltd. Recent Developments and Future Plans

2.5 Johnson & Johnson

2.5.1 Johnson & Johnson Details

2.5.2 Johnson & Johnson Major Business

2.5.3 Johnson & Johnson Prostate Cancer Medicine Product and Solutions

2.5.4 Johnson & Johnson Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Johnson & Johnson Recent Developments and Future Plans

2.6 Pfizer Inc.

2.6.1 Pfizer Inc. Details

2.6.2 Pfizer Inc. Major Business

2.6.3 Pfizer Inc. Prostate Cancer Medicine Product and Solutions

2.6.4 Pfizer Inc. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Pfizer Inc. Recent Developments and Future Plans

2.7 Bayer AG

2.7.1 Bayer AG Details

2.7.2 Bayer AG Major Business

2.7.3 Bayer AG Prostate Cancer Medicine Product and Solutions

2.7.4 Bayer AG Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Bayer AG Recent Developments and Future Plans

2.8 Abbott Laboratories

2.8.1 Abbott Laboratories Details

2.8.2 Abbott Laboratories Major Business

2.8.3 Abbott Laboratories Prostate Cancer Medicine Product and Solutions

2.8.4 Abbott Laboratories Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Abbott Laboratories Recent Developments and Future Plans

2.9 Astellas Pharma Inc.

2.9.1 Astellas Pharma Inc. Details

2.9.2 Astellas Pharma Inc. Major Business

2.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Product and Solutions

2.9.4 Astellas Pharma Inc. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Astellas Pharma Inc. Recent Developments and Future Plans

2.10 Roche Holding AG

2.10.1 Roche Holding AG Details

2.10.2 Roche Holding AG Major Business

2.10.3 Roche Holding AG Prostate Cancer Medicine Product and Solutions

2.10.4 Roche Holding AG Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Roche Holding AG Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Prostate Cancer Medicine Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Prostate Cancer Medicine Players Market Share in 2021

3.2.2 Top 10 Prostate Cancer Medicine Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Prostate Cancer Medicine Players Head Office, Products and Services Provided

3.4 Prostate Cancer Medicine Mergers & Acquisitions

3.5 Prostate Cancer Medicine New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Prostate Cancer Medicine Revenue and Market Share by Type (2017-2022)

4.2 Global Prostate Cancer Medicine Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Prostate Cancer Medicine Revenue Market Share by Application (2017-2022)

5.2 Global Prostate Cancer Medicine Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Prostate Cancer Medicine Revenue by Type (2017-2028)

6.2 North America Prostate Cancer Medicine Revenue by Application (2017-2028)

6.3 North America Prostate Cancer Medicine Market Size by Country

6.3.1 North America Prostate Cancer Medicine Revenue by Country (2017-2028)

6.3.2 United States Prostate Cancer Medicine Market Size and Forecast (2017-2028)

6.3.3 Canada Prostate Cancer Medicine Market Size and Forecast (2017-2028)

6.3.4 Mexico Prostate Cancer Medicine Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Prostate Cancer Medicine Revenue by Type (2017-2028)

7.2 Europe Prostate Cancer Medicine Revenue by Application (2017-2028)

7.3 Europe Prostate Cancer Medicine Market Size by Country

7.3.1 Europe Prostate Cancer Medicine Revenue by Country (2017-2028)

7.3.2 Germany Prostate Cancer Medicine Market Size and Forecast (2017-2028)

7.3.3 France Prostate Cancer Medicine Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Prostate Cancer Medicine Market Size and Forecast (2017-2028)

7.3.5 Russia Prostate Cancer Medicine Market Size and Forecast (2017-2028)

7.3.6 Italy Prostate Cancer Medicine Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Prostate Cancer Medicine Revenue by Type (2017-2028)

8.2 Asia-Pacific Prostate Cancer Medicine Revenue by Application (2017-2028)

8.3 Asia-Pacific Prostate Cancer Medicine Market Size by Region

8.3.1 Asia-Pacific Prostate Cancer Medicine Revenue by Region (2017-2028)

8.3.2 China Prostate Cancer Medicine Market Size and Forecast (2017-2028)

8.3.3 Japan Prostate Cancer Medicine Market Size and Forecast (2017-2028)

8.3.4 South Korea Prostate Cancer Medicine Market Size and Forecast (2017-2028)

8.3.5 India Prostate Cancer Medicine Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Prostate Cancer Medicine Market Size and Forecast (2017-2028)

8.3.7 Australia Prostate Cancer Medicine Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Prostate Cancer Medicine Revenue by Type (2017-2028)

9.2 South America Prostate Cancer Medicine Revenue by Application (2017-2028)

9.3 South America Prostate Cancer Medicine Market Size by Country

9.3.1 South America Prostate Cancer Medicine Revenue by Country (2017-2028)

9.3.2 Brazil Prostate Cancer Medicine Market Size and Forecast (2017-2028)

9.3.3 Argentina Prostate Cancer Medicine Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Prostate Cancer Medicine Revenue by Type (2017-2028)

10.2 Middle East & Africa Prostate Cancer Medicine Revenue by Application (2017-2028)

10.3 Middle East & Africa Prostate Cancer Medicine Market Size by Country

10.3.1 Middle East & Africa Prostate Cancer Medicine Revenue by Country (2017-2028)

10.3.2 Turkey Prostate Cancer Medicine Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Prostate Cancer Medicine Market Size and Forecast (2017-2028)

10.3.4 UAE Prostate Cancer Medicine Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Prostate Cancer Medicine Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Prostate Cancer Medicine Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Prostate Cancer Medicine Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Prostate Cancer Medicine Revenue (USD Million) by Region (2017-2022)

Table 5. Global Prostate Cancer Medicine Revenue Market Share by Region (2023-2028)

Table 6. AstraZeneca plc Corporate Information, Head Office, and Major Competitors

Table 7. AstraZeneca plc Major Business

Table 8. AstraZeneca plc Prostate Cancer Medicine Product and Solutions

Table 9. AstraZeneca plc Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Active Biotech Corporate Information, Head Office, and Major Competitors

Table 11. Active Biotech Major Business

Table 12. Active Biotech Prostate Cancer Medicine Product and Solutions

Table 13. Active Biotech Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Bristol Myers-Squibb Corporate Information, Head Office, and Major Competitors

Table 15. Bristol Myers-Squibb Major Business

Table 16. Bristol Myers-Squibb Prostate Cancer Medicine Product and Solutions

Table 17. Bristol Myers-Squibb Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Teva Pharmaceuticals Industries Ltd. Corporate Information, Head Office, and Major Competitors

Table 19. Teva Pharmaceuticals Industries Ltd. Major Business

Table 20. Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Product and Solutions

Table 21. Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 23. Johnson & Johnson Major Business

Table 24. Johnson & Johnson Prostate Cancer Medicine Product and Solutions

Table 25. Johnson & Johnson Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Pfizer Inc. Corporate Information, Head Office, and Major Competitors

Table 27. Pfizer Inc. Major Business

Table 28. Pfizer Inc. Prostate Cancer Medicine Product and Solutions

Table 29. Pfizer Inc. Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Bayer AG Corporate Information, Head Office, and Major Competitors

Table 31. Bayer AG Major Business

Table 32. Bayer AG Prostate Cancer Medicine Product and Solutions

Table 33. Bayer AG Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 35. Abbott Laboratories Major Business

Table 36. Abbott Laboratories Prostate Cancer Medicine Product and Solutions

Table 37. Abbott Laboratories Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Astellas Pharma Inc. Corporate Information, Head Office, and Major Competitors

Table 39. Astellas Pharma Inc. Major Business

Table 40. Astellas Pharma Inc. Prostate Cancer Medicine Product and Solutions

Table 41. Astellas Pharma Inc. Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Roche Holding AG Corporate Information, Head Office, and Major Competitors

Table 43. Roche Holding AG Major Business

Table 44. Roche Holding AG Prostate Cancer Medicine Product and Solutions

Table 45. Roche Holding AG Prostate Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Prostate Cancer Medicine Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Prostate Cancer Medicine Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Prostate Cancer Medicine by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Prostate Cancer Medicine Players Head Office, Products and Services Provided

Table 50. Prostate Cancer Medicine Mergers & Acquisitions in the Past Five Years

Table 51. Prostate Cancer Medicine New Entrants and Expansion Plans

Table 52. Global Prostate Cancer Medicine Revenue (USD Million) by Type (2017-2022)

Table 53. Global Prostate Cancer Medicine Revenue Share by Type (2017-2022)

Table 54. Global Prostate Cancer Medicine Revenue Forecast by Type (2023-2028)

Table 55. Global Prostate Cancer Medicine Revenue by Application (2017-2022)

Table 56. Global Prostate Cancer Medicine Revenue Forecast by Application (2023-2028)

Table 57. North America Prostate Cancer Medicine Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Prostate Cancer Medicine Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Prostate Cancer Medicine Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Prostate Cancer Medicine Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Prostate Cancer Medicine Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Prostate Cancer Medicine Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Prostate Cancer Medicine Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Prostate Cancer Medicine Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Prostate Cancer Medicine Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Prostate Cancer Medicine Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Prostate Cancer Medicine Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Prostate Cancer Medicine Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Prostate Cancer Medicine Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Prostate Cancer Medicine Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Prostate Cancer Medicine Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Prostate Cancer Medicine Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Prostate Cancer Medicine Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Prostate Cancer Medicine Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Prostate Cancer Medicine Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Prostate Cancer Medicine Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Prostate Cancer Medicine Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Prostate Cancer Medicine Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Prostate Cancer Medicine Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Prostate Cancer Medicine Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Prostate Cancer Medicine Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Prostate Cancer Medicine Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Prostate Cancer Medicine Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Prostate Cancer Medicine Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Prostate Cancer Medicine Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Prostate Cancer Medicine Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Prostate Cancer Medicine Picture

Figure 2. Global Prostate Cancer Medicine Revenue Market Share by Type in 2021

Figure 3. LHRH Antagonists

Figure 4. LHRH Analogs

Figure 5. Antiandrogens

Figure 6. Pipeline Drugs for Hormonal Therapy

Figure 7. Prostate Cancer Medicine Revenue Market Share by Application in 2021

Figure 8. Age Below 55 Picture

Figure 9. Age 55-75 Picture

Figure 10. Age Above 75 Picture

Figure 11. Global Prostate Cancer Medicine Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Prostate Cancer Medicine Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Prostate Cancer Medicine Revenue Market Share by Region (2017-2028)

Figure 14. Global Prostate Cancer Medicine Revenue Market Share by Region in 2021

Figure 15. North America Prostate Cancer Medicine Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Prostate Cancer Medicine Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Prostate Cancer Medicine Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Prostate Cancer Medicine Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Prostate Cancer Medicine Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Prostate Cancer Medicine Market Drivers

Figure 21. Prostate Cancer Medicine Market Restraints

Figure 22. Prostate Cancer Medicine Market Trends

Figure 23. AstraZeneca plc Recent Developments and Future Plans

Figure 24. Active Biotech Recent Developments and Future Plans

Figure 25. Bristol Myers-Squibb Recent Developments and Future Plans

Figure 26. Teva Pharmaceuticals Industries Ltd. Recent Developments and Future Plans

Figure 27. Johnson & Johnson Recent Developments and Future Plans

Figure 28. Pfizer Inc. Recent Developments and Future Plans

Figure 29. Bayer AG Recent Developments and Future Plans

Figure 30. Abbott Laboratories Recent Developments and Future Plans

Figure 31. Astellas Pharma Inc. Recent Developments and Future Plans

Figure 32. Roche Holding AG Recent Developments and Future Plans

Figure 33. Global Prostate Cancer Medicine Revenue Share by Players in 2021

Figure 34. Prostate Cancer Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 35. Global Top 3 Players Prostate Cancer Medicine Revenue Market Share in 2021

Figure 36. Global Top 10 Players Prostate Cancer Medicine Revenue Market Share in 2021

Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 38. Global Prostate Cancer Medicine Revenue Share by Type in 2021

Figure 39. Global Prostate Cancer Medicine Market Share Forecast by Type (2023-2028)

Figure 40. Global Prostate Cancer Medicine Revenue Share by Application in 2021

Figure 41. Global Prostate Cancer Medicine Market Share Forecast by Application (2023-2028)

Figure 42. North America Prostate Cancer Medicine Sales Market Share by Type (2017-2028)

Figure 43. North America Prostate Cancer Medicine Sales Market Share by Application (2017-2028)

Figure 44. North America Prostate Cancer Medicine Revenue Market Share by Country (2017-2028)

Figure 45. United States Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Canada Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Mexico Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Europe Prostate Cancer Medicine Sales Market Share by Type (2017-2028)

Figure 49. Europe Prostate Cancer Medicine Sales Market Share by Application (2017-2028)

Figure 50. Europe Prostate Cancer Medicine Revenue Market Share by Country (2017-2028)

Figure 51. Germany Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. France Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. United Kingdom Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Russia Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Italy Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Asia-Pacific Prostate Cancer Medicine Sales Market Share by Type (2017-2028)

Figure 57. Asia-Pacific Prostate Cancer Medicine Sales Market Share by Application (2017-2028)

Figure 58. Asia-Pacific Prostate Cancer Medicine Revenue Market Share by Region (2017-2028)

Figure 59. China Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Japan Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. South Korea Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. India Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Southeast Asia Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Australia Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. South America Prostate Cancer Medicine Sales Market Share by Type (2017-2028)

Figure 66. South America Prostate Cancer Medicine Sales Market Share by Application (2017-2028)

Figure 67. South America Prostate Cancer Medicine Revenue Market Share by Country (2017-2028)

Figure 68. Brazil Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Argentina Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Middle East and Africa Prostate Cancer Medicine Sales Market Share by Type (2017-2028)

Figure 71. Middle East and Africa Prostate Cancer Medicine Sales Market Share by Application (2017-2028)

Figure 72. Middle East and Africa Prostate Cancer Medicine Revenue Market Share by Country (2017-2028)

Figure 73. Turkey Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Saudi Arabia Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. UAE Prostate Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Methodology

Figure 77. Research Process and Data Source

License Type

Quick Contact

Our Clients

Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz